Curanex Financial Statements From 2010 to 2026

CURX Stock   0.36  0.01  2.70%   
Curanex Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Curanex Pharmaceuticals' valuation are provided below:
Curanex Pharmaceuticals Common does not presently have any fundamental signals for analysis.
Check Curanex Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Curanex Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Curanex financial statements analysis is a perfect complement when working with Curanex Pharmaceuticals Valuation or Volatility modules.
Check out the analysis of Curanex Pharmaceuticals Correlation against competitors.

Curanex Pharmaceuticals Common Company Shares Outstanding Analysis

Curanex Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Curanex Pharmaceuticals Shares Outstanding

    
  28.34 M  
Most of Curanex Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Curanex Pharmaceuticals Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Curanex Pharmaceuticals Common has 28.34 M of shares currently outstending. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is notably lower than that of the firm.

Curanex Pharmaceuticals Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Curanex Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Curanex Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Curanex Pharmaceuticals competition to find correlations between indicators driving Curanex Pharmaceuticals's intrinsic value. More Info.
Curanex Pharmaceuticals Common is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Curanex Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

About Curanex Pharmaceuticals Financial Statements

Curanex Pharmaceuticals investors use historical fundamental indicators, such as Curanex Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Curanex Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Curanex Stock Analysis

When running Curanex Pharmaceuticals' price analysis, check to measure Curanex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curanex Pharmaceuticals is operating at the current time. Most of Curanex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Curanex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curanex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Curanex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.